A weekly prescription injection with the same active ingredient as Ozempic® and Wegovy®. By working with FDA-regulated compounding pharmacies, Bioverse can offer this medication in personalized doses to fit your unique needs.
80% of Semaglutide users report feeling healthier since starting weight loss treatment through Bioverse
Why you will love weight loss by Bioverse
Weight loss plan tailored to your lifestyle and goals, with unique dosages, unlimited ongoing support, and medication adjustments anytime, if appropriate.
How it works
1
Complete a Quick Medical Intake
Answer some questions about your health history, lifestyle, and goals, 100% online.
2
Provider evaluation
A medical professional will review your intake and determine what’s right for you.
3
Personalized plan
If prescribed, you’ll get a customized holistic plan designed to work for you.
4
Continuous Support
Unlimited online access to follow-ups, adjustments, and answers to questions.
Compounded Semaglutide for your weight loss goals
In-stock
$32 to start today. Paid in full at checkout.
A once-a-week injection, compounded GLP-1s through Bioverse contain the same active ingredient as Ozempic® and Wegovy®.
Meet Compounded Semaglutide
How to take
- Compounded GLP-1s are only one injection per week
- If prescribed, a licensed provider will include treatment instructions with your weight loss plan
Potential side effects
- Some common side effects of Compounded Segmaglutide include nausea, diarrhea, and vomiting
- To help your body adjust, a fast-acting anti-nausea medication is included with treatment at no extra cost, if eligible
Personalized Treatment
- If appropriate, a provider will prescribe a GLP-1 injection based on your health history and weight loss goals
- Compounded medications are prescribed by licensed providers and made in certified pharmacies.
- Your dosage and how fast you increase your dosage is personalized to you, and your provider can help make adjustments as needed, anytime
Compounded semaglutide is not approved by the FDA, and the FDA does not verify its safety, effectiveness, or quality.
All prescription products require an online consultation with a Bioverse licensed healthcare provider, who will determine if a prescription is medically appropriate.
Wegovy® (semaglutide) and Ozempic® (semaglutide) are not compounded. Wegovy® is FDA-approved for weight loss; Ozempic® is FDA-approved for type 2 diabetes but may be prescribed off-label for weight management at a provider’s discretion.
Affordable GLP-1
© 2025 BIOVERSE, Inc. All rights reserved.
Personalized Treatment Plans
Affordable GLP-1s
$32/week for a 6-month supply, Bioverse Weight Loss aims to be the most affordable GLP-1 program.
Lose weight in your first month
In a 30-day window, participants reported losing an average of 11 pounds* while following Bioverse’s compounded GLP-1 regimen, paired with a healthy diet and exercise.
*Individual results vary.
Competitive comparison: Price comparison across 12 leading providers (as of December 2024) indicates one of the most cost-effective options for semaglutide-based weight-loss plans over a 12-month period.
You could lose:
-
5
4
lbs
Starting weight:
270lbs
Lose up to
20%
People lost an average of 15% (up to 20%) bodyweight in a 68-week clinical trial study of Wegovy® (semaglutide)*
*Along with a reduced calorie diet and increased exercise. In a 68-week clinical study of Wegovy®, about 1 in 3 adults with obesity or with overweight and weight-related medical problems achieved 20% weight loss. Average weight loss achieved was 15%. Wegovy® is a registered trademark of Novo Nordisk A/S.
Average weight loss of 11 lbs in the first month*
through Weight Loss by Bioverse with compounded GLP-1 injections
Compounded drug products are not approved or evaluated for safety, efficacy, or quality by the FDA.
*Based on self-reported data from approximately 1900 Bioverse customers on a personalized treatment plan including compounded GLP-1 injections, along with a reduced calorie diet and exercise. Customers reported their weight at their initial medical consultation and their first check-in approximately 4 weeks later. Stopping weight loss treatment has been shown to result in weight regain.